AtaiBeckley Inc. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
4.030
-0.060 (-1.47%)
At close: Apr 17, 2026, 4:00 PM EDT
4.080
+0.050 (1.24%)
After-hours: Apr 17, 2026, 7:57 PM EDT
AtaiBeckley Market Cap
AtaiBeckley has a market cap or net worth of $1.47 billion as of April 17, 2026. Its market cap has increased by 400.84% in one year.
Market Cap
1.47B
Enterprise Value
1.22B
1-Year Change
400.84%
Ranking
Category
Stock Price
$4.03
Market Cap Chart
Since the IPO on June 18, 2021, AtaiBeckley's market cap has decreased from $2.29B to $1.47B, a decrease of -35.77%. That is a compound annual growth rate of -8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.47B | -1.05% |
| Dec 31, 2025 | 1.49B | 565.64% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.58B |
| Bicara Therapeutics | 1.57B |
| Iovance Biotherapeutics | 1.57B |
| Ardelyx | 1.54B |
| Biohaven | 1.51B |
| Viridian Therapeutics | 1.50B |
| Monte Rosa Therapeutics | 1.50B |
| Immatics | 1.46B |